Report
Jay Lee
EUR 100.00 For Business Accounts Only

A Chinese drug distributor, manufacturer, and retail pharmacy chain concentrated in Eastern China.

SPH is a vertically integrated drug distributor that also operates a large drug manufacturer and retail pharmacy chain. Chinese healthcare industries have grown faster than gross domestic product, or GDP, and will continue to grow due to aging demographics, increased urbanization, a larger middle class, and rising disease rates.Distribution is 65% of operating profit as of 2017. After SPH's acquisition of Cardinal’s China operations, it will be the second-largest distributor in China. Over 65% o...
Underlying
Shanghai Pharmaceuticals Holding Co. Ltd. Class H

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Jay Lee

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch